| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | ATR CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 FASTK FER FES STK39 DCLK2 PAK5 TEC TGFBR2 TNNI3K RNASEL IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 2.98e-06 | 600 | 255 | 23 | GO:0004672 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ATR IP6K3 CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 CEPT1 FASTK FER FES STK39 DCLK2 PARP12 PARP11 PAK5 TEC TEP1 TGFBR2 TNNI3K RNASEL IRAK3 MAPK1 MAPK4 STKLD1 POLG2 EIF2AK2 | 1.03e-05 | 938 | 255 | 29 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ATR IP6K3 CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 FASTK FER FES STK39 DCLK2 PAK5 TEC TGFBR2 TNNI3K RNASEL IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 1.47e-05 | 709 | 255 | 24 | GO:0016773 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF845 ZNF148 ZNF585A ZNF658 ZNF175 ZNF180 TRPS1 ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF610 MED12 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 BCL11B GZF1 CTCF ZNF256 ZKSCAN3 ZNF814 ZNF888 ZNF721 ZNF83 EMX2 ZNF582 | 2.11e-05 | 1459 | 255 | 38 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF845 ZNF148 ZNF585A ZNF658 ZNF175 ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF610 MED12 ZNF345 ZNF573 ZNF577 ZNF570 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 BCL11B GZF1 CTCF ZNF256 ZKSCAN3 ZNF814 ZNF888 ZNF721 ZNF83 EMX2 | 2.29e-05 | 1244 | 255 | 34 | GO:0000978 |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 2.50e-05 | 46 | 255 | 6 | GO:0004715 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF845 ZNF148 ZNF585A ZNF658 ZNF175 ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF610 MED12 ZNF345 ZNF573 ZNF577 ZNF570 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 BCL11B GZF1 CTCF ZNF256 ZKSCAN3 ZNF814 ZNF888 ZNF721 ZNF83 EMX2 | 3.53e-05 | 1271 | 255 | 34 | GO:0000987 |
| GeneOntologyMolecularFunction | kinase activity | ATR IP6K3 CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 FASTK FER FES STK39 DCLK2 PAK5 TEC TGFBR2 TNNI3K RNASEL IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 4.85e-05 | 764 | 255 | 24 | GO:0016301 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF845 ZNF148 ZNF585A ZNF658 ZNF175 ZNF180 TRPS1 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 BCL11A ZNF551 ZNF331 ZNF610 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF397 ZNF419 ZNF12 BCL11B GZF1 CTCF ZNF256 ZKSCAN3 ZNF814 ZNF888 ZNF721 ZNF83 EMX2 ZBTB3 ZNF582 | 5.54e-05 | 1412 | 255 | 36 | GO:0000981 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | ATR CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 FASTK STK39 DCLK2 PAK5 TGFBR2 TNNI3K IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 6.49e-05 | 446 | 255 | 17 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine kinase activity | ATR CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 FASTK STK39 DCLK2 PAK5 TNNI3K MAPK1 MAPK4 EIF2AK2 | 2.54e-04 | 363 | 255 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 8.92e-04 | 120 | 255 | 7 | GO:0004222 | |
| GeneOntologyMolecularFunction | oxoglutarate dehydrogenase (succinyl-transferring) activity | 9.58e-04 | 4 | 255 | 2 | GO:0004591 | |
| GeneOntologyCellularComponent | myosin filament | 1.15e-05 | 25 | 256 | 5 | GO:0032982 | |
| Domain | - | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 ZNF800 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF721 ZNF83 ZBTB3 ZNF582 | 4.51e-16 | 679 | 250 | 41 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 TRPS1 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF721 ZNF83 ZBTB3 ZNF582 | 9.12e-16 | 693 | 250 | 41 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 ZNF800 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF721 ZNF83 ZBTB3 ZNF582 | 9.58e-16 | 694 | 250 | 41 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 TRPS1 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 BRPF1 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 ZNF800 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF721 ZNF83 ZBTB3 ZNF582 | 1.64e-15 | 775 | 250 | 43 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 TRPS1 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 BRPF1 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 ZNF800 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF721 ZNF83 ZBTB3 ZNF582 | 1.79e-15 | 777 | 250 | 43 | PS00028 |
| Domain | Znf_C2H2-like | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 TRPS1 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 BRPF1 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 ZNF800 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF721 ZNF83 ZBTB3 ZNF582 | 4.20e-15 | 796 | 250 | 43 | IPR015880 |
| Domain | Znf_C2H2 | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 TRPS1 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 BRPF1 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 ZNF800 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF721 ZNF83 ZBTB3 ZNF582 | 6.24e-15 | 805 | 250 | 43 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 TRPS1 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 BRPF1 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 ZNF800 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF721 ZNF83 ZBTB3 ZNF582 | 7.11e-15 | 808 | 250 | 43 | SM00355 |
| Domain | zf-C2H2_6 | ZNF845 ZNF155 ZNF658 ZNF267 ZNF621 ZNF551 ZNF331 ZNF345 ZNF573 ZNF570 ZNF329 ZNF865 ZNF710 ZNF419 ZNF12 GZF1 ZNF256 ZNF814 ZNF721 ZNF582 | 9.32e-09 | 314 | 250 | 20 | PF13912 |
| Domain | KRAB | ZNF845 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 ZNF267 ZNF621 ZNF551 ZNF331 ZNF610 ZNF573 ZNF577 ZNF570 ZNF419 ZNF12 ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF582 | 1.66e-08 | 358 | 250 | 21 | PS50805 |
| Domain | KRAB | ZNF845 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 ZNF267 ZNF621 ZNF551 ZNF331 ZNF610 ZNF573 ZNF577 ZNF570 ZNF419 ZNF12 ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF582 | 1.66e-08 | 358 | 250 | 21 | PF01352 |
| Domain | KRAB | ZNF845 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 ZNF267 ZNF621 ZNF551 ZNF331 ZNF610 ZNF573 ZNF577 ZNF570 ZNF419 ZNF12 ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF582 | 2.80e-08 | 369 | 250 | 21 | SM00349 |
| Domain | KRAB | ZNF845 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 ZNF267 ZNF621 ZNF551 ZNF331 ZNF610 ZNF573 ZNF577 ZNF570 ZNF419 ZNF12 ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF582 | 2.94e-08 | 370 | 250 | 21 | IPR001909 |
| Domain | PROTEIN_KINASE_ATP | CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 FER FES STK39 DCLK2 PAK5 TEC TGFBR2 TNNI3K RNASEL IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 1.06e-06 | 459 | 250 | 21 | PS00107 |
| Domain | Prot_kinase_dom | CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 FER FES STK39 DCLK2 PAK5 TEC TGFBR2 TNNI3K RNASEL IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 2.88e-06 | 489 | 250 | 21 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 FER FES STK39 DCLK2 PAK5 TEC TGFBR2 TNNI3K RNASEL IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 3.27e-06 | 493 | 250 | 21 | PS50011 |
| Domain | Protein_kinase_ATP_BS | CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 FER FES STK39 DCLK2 PAK5 TEC TGFBR2 TNNI3K MAPK1 MAPK4 EIF2AK2 | 3.80e-06 | 379 | 250 | 18 | IPR017441 |
| Domain | Kinase-like_dom | ATR CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 PTK6 TYK2 FER FES STK39 DCLK2 PAK5 TEC TGFBR2 TNNI3K RNASEL IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 4.12e-06 | 542 | 250 | 22 | IPR011009 |
| Domain | Tox-GHH_dom | 9.39e-06 | 4 | 250 | 3 | IPR028916 | |
| Domain | Tox-GHH | 9.39e-06 | 4 | 250 | 3 | PF15636 | |
| Domain | Ten_N | 9.39e-06 | 4 | 250 | 3 | IPR009471 | |
| Domain | Ten_N | 9.39e-06 | 4 | 250 | 3 | PF06484 | |
| Domain | TENEURIN_N | 9.39e-06 | 4 | 250 | 3 | PS51361 | |
| Domain | Ank | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 TNNI3K RNASEL KANK4 TANC1 MYO16 | 1.30e-05 | 228 | 250 | 13 | PF00023 |
| Domain | YD | 2.32e-05 | 5 | 250 | 3 | IPR006530 | |
| Domain | ANK | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 TNNI3K RNASEL KANK4 TANC1 MYO16 | 3.56e-05 | 251 | 250 | 13 | SM00248 |
| Domain | ANK_REPEAT | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 TNNI3K RNASEL KANK4 TANC1 MYO16 | 3.86e-05 | 253 | 250 | 13 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 TNNI3K RNASEL KANK4 TANC1 MYO16 | 4.02e-05 | 254 | 250 | 13 | IPR020683 |
| Domain | ANK_REP_REGION | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 TNNI3K RNASEL KANK4 TANC1 MYO16 | 4.02e-05 | 254 | 250 | 13 | PS50297 |
| Domain | Ankyrin_rpt | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 TNNI3K RNASEL KANK4 TANC1 MYO16 | 5.53e-05 | 262 | 250 | 13 | IPR002110 |
| Domain | - | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 RNASEL KANK4 TANC1 MYO16 | 1.35e-04 | 248 | 250 | 12 | 1.25.40.20 |
| Domain | Ank_2 | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 RNASEL TANC1 MYO16 | 1.58e-04 | 215 | 250 | 11 | PF12796 |
| Domain | 2-oxogl_dehyd_N | 1.78e-04 | 2 | 250 | 2 | IPR032106 | |
| Domain | 2-oxogl_dehyd_N | 1.78e-04 | 2 | 250 | 2 | PF16078 | |
| Domain | Tyr-prot_kinase_Fes/Fps | 1.78e-04 | 2 | 250 | 2 | IPR016250 | |
| Domain | Pkinase | CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 STK39 DCLK2 PAK5 TGFBR2 RNASEL IRAK3 MAPK1 MAPK4 STKLD1 EIF2AK2 | 2.03e-04 | 381 | 250 | 15 | PF00069 |
| Domain | TPR_7 | 2.65e-04 | 10 | 250 | 3 | PF13176 | |
| Domain | Ser/Thr_kinase_AS | CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 STK39 DCLK2 PAK5 TGFBR2 TNNI3K IRAK3 MAPK1 MAPK4 EIF2AK2 | 3.42e-04 | 357 | 250 | 14 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 STK39 DCLK2 PAK5 TGFBR2 TNNI3K IRAK3 MAPK1 MAPK4 EIF2AK2 | 3.94e-04 | 362 | 250 | 14 | PS00108 |
| Domain | Rhs_assc_core | 5.31e-04 | 3 | 250 | 2 | IPR022385 | |
| Domain | 2oxoglutarate_DH_E1 | 5.31e-04 | 3 | 250 | 2 | IPR011603 | |
| Domain | KGD_C | 5.31e-04 | 3 | 250 | 2 | IPR031717 | |
| Domain | OxoGdeHyase_C | 5.31e-04 | 3 | 250 | 2 | PF16870 | |
| Domain | NHL | 6.14e-04 | 13 | 250 | 3 | PS51125 | |
| Domain | PH_dom-like | ARHGAP42 MCF2L2 FRS3 RABGAP1 LYST MTMR10 TYK2 OSBPL1A OSBPL8 PLEKHA8 RANBP3 FRMPD2 ARHGEF18 TEC DAPP1 | 6.54e-04 | 426 | 250 | 15 | IPR011993 |
| Domain | SH2 | 6.99e-04 | 110 | 250 | 7 | SM00252 | |
| Domain | SH2 | 7.38e-04 | 111 | 250 | 7 | PS50001 | |
| Domain | SH2 | 7.78e-04 | 112 | 250 | 7 | IPR000980 | |
| Domain | - | 7.78e-04 | 112 | 250 | 7 | 3.30.505.10 | |
| Domain | KN_motif | 1.05e-03 | 4 | 250 | 2 | IPR021939 | |
| Domain | GLTP | 1.05e-03 | 4 | 250 | 2 | PF08718 | |
| Domain | Glycolipid_transfer_prot_dom | 1.05e-03 | 4 | 250 | 2 | IPR014830 | |
| Domain | KN_motif | 1.05e-03 | 4 | 250 | 2 | PF12075 | |
| Domain | S_TKc | CDK15 MAPKAPK2 RPS6KB2 PAK6 MAP3K1 STK39 DCLK2 PAK5 TGFBR2 RNASEL MAPK1 MAPK4 EIF2AK2 | 1.15e-03 | 359 | 250 | 13 | SM00220 |
| Domain | Myosin_head_motor_dom | 1.62e-03 | 38 | 250 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.62e-03 | 38 | 250 | 4 | PS51456 | |
| Domain | Myosin_head | 1.62e-03 | 38 | 250 | 4 | PF00063 | |
| Domain | MYSc | 1.62e-03 | 38 | 250 | 4 | SM00242 | |
| Domain | Myosin_tail_1 | 1.67e-03 | 18 | 250 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.67e-03 | 18 | 250 | 3 | IPR002928 | |
| Domain | Pkinase_Tyr | 1.77e-03 | 129 | 250 | 7 | PF07714 | |
| Domain | Pep_M12B_propep | 1.78e-03 | 39 | 250 | 4 | PF01562 | |
| Domain | Peptidase_M12B_N | 1.78e-03 | 39 | 250 | 4 | IPR002870 | |
| Domain | USP_CS | 1.90e-03 | 66 | 250 | 5 | IPR018200 | |
| Domain | PDEase | 1.96e-03 | 19 | 250 | 3 | IPR023088 | |
| Domain | Myosin-like_IQ_dom | 1.96e-03 | 19 | 250 | 3 | IPR027401 | |
| Domain | - | 1.96e-03 | 19 | 250 | 3 | 4.10.270.10 | |
| Domain | PLAC | 1.96e-03 | 19 | 250 | 3 | PS50900 | |
| Domain | PLAC | 1.96e-03 | 19 | 250 | 3 | IPR010909 | |
| Domain | DISINTEGRIN_1 | 1.96e-03 | 40 | 250 | 4 | PS00427 | |
| Domain | Reprolysin | 1.96e-03 | 40 | 250 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 1.96e-03 | 40 | 250 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.96e-03 | 40 | 250 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 1.96e-03 | 40 | 250 | 4 | IPR001590 | |
| Domain | EGF-like_dom | ADAM21 ADAM8 TENM2 MEP1B FBN2 LAMB2 TENM4 CELSR3 HMCN1 TENM1 | 2.00e-03 | 249 | 250 | 10 | IPR000742 |
| Domain | ZINC_PROTEASE | 2.04e-03 | 98 | 250 | 6 | PS00142 | |
| Domain | ARM-type_fold | USP34 GBF1 ATR TSC2 LYST MAP3K1 ITPR1 DOCK3 FRYL THADA INTS4 STKLD1 | 2.14e-03 | 339 | 250 | 12 | IPR016024 |
| Domain | Disintegrin_dom | 2.15e-03 | 41 | 250 | 4 | IPR001762 | |
| Domain | EGF_1 | ADAM21 ADAM8 TENM2 MEP1B FBN2 LAMB2 TENM4 CELSR3 HMCN1 TENM1 | 2.37e-03 | 255 | 250 | 10 | PS00022 |
| Domain | SH2 | 2.38e-03 | 101 | 250 | 6 | PF00017 | |
| Domain | - | ARHGAP42 MCF2L2 FRS3 RABGAP1 MTMR10 OSBPL1A OSBPL8 PLEKHA8 RANBP3 FRMPD2 ARHGEF18 TEC DAPP1 | 2.45e-03 | 391 | 250 | 13 | 2.30.29.30 |
| Domain | USP_1 | 2.46e-03 | 70 | 250 | 5 | PS00972 | |
| Domain | E1_dh | 2.58e-03 | 6 | 250 | 2 | PF00676 | |
| Domain | DH_E1 | 2.58e-03 | 6 | 250 | 2 | IPR001017 | |
| Domain | Kinesin-like | 2.58e-03 | 6 | 250 | 2 | IPR022164 | |
| Domain | DUF3694 | 2.58e-03 | 6 | 250 | 2 | PF12473 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.60e-03 | 138 | 250 | 7 | IPR001245 | |
| Domain | UCH | 2.62e-03 | 71 | 250 | 5 | PF00443 | |
| Domain | USP_2 | 2.62e-03 | 71 | 250 | 5 | PS00973 | |
| Domain | PDEase_I | 2.64e-03 | 21 | 250 | 3 | PF00233 | |
| Domain | PDEASE_I | 2.64e-03 | 21 | 250 | 3 | PS00126 | |
| Domain | PDEase_CS | 2.64e-03 | 21 | 250 | 3 | IPR023174 | |
| Domain | USP_3 | 2.79e-03 | 72 | 250 | 5 | PS50235 | |
| Domain | USP_dom | 2.79e-03 | 72 | 250 | 5 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 2.79e-03 | 72 | 250 | 5 | IPR001394 | |
| Domain | EGF-like_CS | ADAM21 ADAM8 TENM2 MEP1B FBN2 LAMB2 TENM4 CELSR3 HMCN1 TENM1 | 2.81e-03 | 261 | 250 | 10 | IPR013032 |
| Domain | SH3_domain | 2.93e-03 | 220 | 250 | 9 | IPR001452 | |
| Domain | FCH | 3.02e-03 | 22 | 250 | 3 | PF00611 | |
| Domain | Quino_amine_DH_bsu | 3.02e-03 | 22 | 250 | 3 | IPR011044 | |
| Domain | - | 3.02e-03 | 22 | 250 | 3 | 1.10.1300.10 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 PDE2A GBF1 ZNF585A MFHAS1 MAPKAPK2 TSC2 LYST ACOX3 KIAA2013 TYK2 KMT2C BMP4 SGSM2 PKD1 USP7 UVRAG MED12 DOCK3 PITPNM2 SZT2 LAMB2 FRYL TEP1 ZNF865 THADA SCAP CELSR3 OGDHL TANC1 PC | 3.87e-10 | 1105 | 262 | 31 | 35748872 |
| Pubmed | USP34 PDE2A SPTAN1 TRPS1 ZMYND8 MCF2L2 USP25 TSC2 RAD54L2 MTMR10 ZNF331 MTA3 RSPH1 SGSM2 OSBPL1A MIB1 PKD1 USP7 OSBPL8 DCLK2 METAP2 DOCK3 TTC28 GIT1 ZNF329 STAM ARHGAP5 CELSR3 TTC17 ZNF83 PC | 1.34e-08 | 1285 | 262 | 31 | 35914814 | |
| Pubmed | MYH10 LEMD3 ZMYND8 USP25 PPP1R13L MTMR10 ACOX3 BMP4 KANK1 FBN2 PKD1 ASCC3 ZNF329 LAMB2 STAM EPG5 ARHGAP5 ZNF83 ZBTB3 PLIN3 | 2.94e-08 | 591 | 262 | 20 | 15231748 | |
| Pubmed | USP34 ZNF148 TRPS1 ZMYND8 ZNF362 BCL11A SQOR ADCY6 TYK2 ZNF610 VPS52 FBN2 MTA3 ANAPC1 BRPF1 USP7 STK39 ASCC3 TTC28 UACA PDCD2L TEP1 THADA BCL11B ARHGEF33 CTCF WDR6 TANC1 | 3.16e-08 | 1116 | 262 | 28 | 31753913 | |
| Pubmed | 1.91e-07 | 147 | 262 | 10 | 29576527 | ||
| Pubmed | GBF1 LCMT2 KIAA2013 ZNF462 ZNF610 OSBPL8 KLHL14 MED12 DOCK3 KIF13B UACA ARHGEF18 ZNF407 ATP8B2 THADA SCAP ADAMTSL2 | 2.54e-07 | 493 | 262 | 17 | 15368895 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USP34 ZNF845 GBF1 ZNF658 LEMD3 PEX12 ZNF362 ERGIC2 HNRNPA2B1 ZNF551 ZNF462 VPS52 FBN2 ANAPC1 OSBPL8 TIMELESS MED12 GPI ZNF329 LAMB2 ZNF407 ZNF12 ORC5 ZNF800 GZF1 SLC12A2 CTCF | 5.09e-07 | 1203 | 262 | 27 | 29180619 |
| Pubmed | 6.35e-07 | 129 | 262 | 9 | 23022380 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 1.68e-06 | 4 | 262 | 3 | 12000766 | |
| Pubmed | Toll-like receptor 3-elicited MAPK activation induces stabilization of interferon-β mRNA. | 1.68e-06 | 4 | 262 | 3 | 22200507 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 1.68e-06 | 4 | 262 | 3 | 10225957 | |
| Pubmed | 1.68e-06 | 4 | 262 | 3 | 24101214 | ||
| Pubmed | GBF1 LEMD3 TSC2 RABGAP1 ARFIP2 LYST ITPR1 OSBPL1A OSBPL8 UVRAG SCAP SLC12A2 WDR6 TENM1 AKAP11 PCDH7 | 1.69e-06 | 504 | 262 | 16 | 34432599 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 1.84e-06 | 49 | 262 | 6 | 9630514 | |
| Pubmed | USP34 ZNF148 TRPS1 ZMYND8 ZNF217 RABGAP1 ZNF462 ANAPC1 ASCC3 MED12 TTC28 WDR6 ZKSCAN3 PC | 4.12e-06 | 418 | 262 | 14 | 34709266 | |
| Pubmed | Graded expression of Zfp462 in the embryonic mouse cerebral cortex. | 4.18e-06 | 5 | 262 | 3 | 17207666 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | CDK15 PAK6 PTK6 TYK2 FASTK FER FES DCLK2 KLHL14 TNNI3K IRAK3 MAPK4 EIF2AK2 | 5.79e-06 | 372 | 262 | 13 | 22939624 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 GBF1 ZNF148 ATR LEMD3 EXT1 ERGIC2 ADCY6 LRRC47 ANGPT4 TIMELESS GPI TM9SF1 OGDH ATP8B2 TGOLN2 TGFBR2 THADA SCAP INTS4 SLC25A52 PC PLIN3 | 6.53e-06 | 1061 | 262 | 23 | 33845483 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYH10 SPTAN1 COPB2 SQOR ASCC3 GPI TTC28 UACA MYH7B MYO18A EIF2AK2 | 6.83e-06 | 268 | 262 | 11 | 33024031 |
| Pubmed | 8.31e-06 | 6 | 262 | 3 | 26702831 | ||
| Pubmed | USP34 GBF1 ADCY6 ZNF462 KMT2C OSBPL8 TTC28 SCAP TENM4 AKAP11 | 8.99e-06 | 225 | 262 | 10 | 12168954 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PHYKPL MYH10 MAPKAPK2 TRPS1 RABGAP1 ZNF362 HNRNPA2B1 PTK6 ZNF331 TYK2 ZNF462 KMT2C MTA3 SGSM2 EXOC6B DCLK2 PITPNM2 UACA B3GALNT2 FRMPD2 ARHGEF18 FRYL TEP1 OGDH ANKRD44 THADA TTC17 TANC1 | 9.19e-06 | 1489 | 262 | 28 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 SPTAN1 TSC2 PAK6 LYST OSBPL8 DCLK2 UVRAG KIF13B TTC28 GIT1 RANBP3 PAK5 FRYL SLC12A2 AKAP11 TANC1 MAPK4 PC PCDH7 | 9.94e-06 | 861 | 262 | 20 | 36931259 |
| Pubmed | 1.39e-05 | 20 | 262 | 4 | 26511239 | ||
| Pubmed | FGFR1-Frs2/3 signalling maintains sensory progenitors during inner ear hair cell formation. | 1.39e-05 | 20 | 262 | 4 | 24465223 | |
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 12915301 | ||
| Pubmed | 1.58e-05 | 42 | 262 | 5 | 34673265 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 1.64e-05 | 106 | 262 | 7 | 31024071 | |
| Pubmed | 1.70e-05 | 21 | 262 | 4 | 7865130 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | USP34 ATR MAPKAPK2 RPS6KB2 LYST ACOX3 MAP3K1 PTK6 MTA3 ANAPC1 FER USP7 OSBPL8 METAP2 UACA PAK5 TEC IRAK3 AKAP11 MAPK1 | 2.19e-05 | 910 | 262 | 20 | 36736316 |
| Pubmed | 2.25e-05 | 75 | 262 | 6 | 20637190 | ||
| Pubmed | Self-stabilizing regulation of deubiquitinating enzymes in an enzymatic activity-dependent manner. | 2.30e-05 | 8 | 262 | 3 | 33864866 | |
| Pubmed | 2.30e-05 | 8 | 262 | 3 | 10331952 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.48e-05 | 202 | 262 | 9 | 33005030 | |
| Pubmed | 3.43e-05 | 9 | 262 | 3 | 15569927 | ||
| Pubmed | 3.43e-05 | 9 | 262 | 3 | 31491533 | ||
| Pubmed | ZNF148 TRPS1 ZMYND8 ZNF217 ZNF362 MTA3 USP7 MED12 RANBP3 INTS4 | 4.03e-05 | 268 | 262 | 10 | 33640491 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 ATR LEMD3 TSC2 EXT1 RABGAP1 ERGIC2 KIAA2013 ITPR1 FBN2 TIMELESS TM9SF1 B3GALNT2 LAMB2 TGOLN2 THADA SCAP SLC12A2 CELSR3 TTC17 EIF2AK2 PCDH7 PLIN3 | 4.55e-05 | 1201 | 262 | 23 | 35696571 |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 4.76e-05 | 125 | 262 | 7 | 32891193 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 4.77e-05 | 170 | 262 | 8 | 23314748 | |
| Pubmed | ZNF148 ZNF175 ZNF180 TRPS1 ZMYND8 ZBTB8B ZNF462 ZNF610 MTA3 BRPF1 PARP12 NRAP ZNF397 ZNF710 ZNF419 CTCF ZKSCAN3 ZNF721 | 4.78e-05 | 808 | 262 | 18 | 20412781 | |
| Pubmed | 4.88e-05 | 10 | 262 | 3 | 38713721 | ||
| Pubmed | Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease. | 5.65e-05 | 2 | 262 | 2 | 24158982 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 12628722 | ||
| Pubmed | The novel mechanism of Med12-mediated drug resistance in a TGFBR2-independent manner. | 5.65e-05 | 2 | 262 | 2 | 35461070 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 12871378 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 37144518 | ||
| Pubmed | Acrofacial dysostosis in a patient with the TSC2-PKD1 contiguous gene syndrome. | 5.65e-05 | 2 | 262 | 2 | 11836366 | |
| Pubmed | FER and FES tyrosine kinase fusions in follicular T-cell lymphoma. | 5.65e-05 | 2 | 262 | 2 | 31746983 | |
| Pubmed | Mutation of the Na-K-Cl co-transporter gene Slc12a2 results in deafness in mice. | 5.65e-05 | 2 | 262 | 2 | 10401008 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 18060739 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 31176519 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 21651764 | ||
| Pubmed | Simvastatin downregulates expression of TGF-βRII and inhibits proliferation of A549 cells via ERK. | 5.65e-05 | 2 | 262 | 2 | 25631750 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 8607977 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 21636578 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 32906142 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 35142283 | ||
| Pubmed | Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease. | 5.65e-05 | 2 | 262 | 2 | 23457523 | |
| Pubmed | Polycystin 1 is required for the structural integrity of blood vessels. | 5.65e-05 | 2 | 262 | 2 | 10677526 | |
| Pubmed | The mouse homologue of the polycystic kidney disease gene (Pkd1) is a single-copy gene. | 5.65e-05 | 2 | 262 | 2 | 8661056 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 23178117 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 34876325 | ||
| Pubmed | Mutation of the gene encoding fibrillin-2 results in syndactyly in mice. | 5.65e-05 | 2 | 262 | 2 | 11285249 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 25355409 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 2322568 | ||
| Pubmed | Fps/Fes and Fer protein-tyrosinekinases play redundant roles in regulating hematopoiesis. | 5.65e-05 | 2 | 262 | 2 | 12901971 | |
| Pubmed | In vivo regulation of the dsRNA-dependent protein kinase PKR by the cellular glycoprotein p67. | 5.65e-05 | 2 | 262 | 2 | 11123929 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 15567065 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 20463172 | ||
| Pubmed | Fer kinase limits neutrophil chemotaxis toward end target chemoattractants. | 5.65e-05 | 2 | 262 | 2 | 23355730 | |
| Pubmed | Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model. | 5.65e-05 | 2 | 262 | 2 | 24994926 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 20633534 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 17343268 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 19109428 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 12196208 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 18068700 | ||
| Pubmed | Basal body stability and ciliogenesis requires the conserved component Poc1. | 5.65e-05 | 2 | 262 | 2 | 20008567 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 31757932 | ||
| Pubmed | Poc1A and Poc1B act together in human cells to ensure centriole integrity. | 5.65e-05 | 2 | 262 | 2 | 23015594 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 11994747 | ||
| Pubmed | USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion. | 5.65e-05 | 2 | 262 | 2 | 39128723 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 16156900 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 20442269 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 12740379 | ||
| Pubmed | CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis. | 5.65e-05 | 2 | 262 | 2 | 15465497 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 32604168 | ||
| Pubmed | Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background. | 5.65e-05 | 2 | 262 | 2 | 19237661 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 15661870 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 12620233 | ||
| Pubmed | The original shaker-with-syndactylism mutation (sy) is a contiguous gene deletion syndrome. | 5.65e-05 | 2 | 262 | 2 | 9799839 | |
| Pubmed | BMP4 and FGF3 haplotypes increase the risk of tendinopathy in volleyball athletes. | 5.65e-05 | 2 | 262 | 2 | 24661680 | |
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 8530105 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 16809306 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 24683199 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 20618940 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 16895559 | ||
| Pubmed | 5.65e-05 | 2 | 262 | 2 | 15994831 | ||
| Pubmed | The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. | 5.65e-05 | 2 | 262 | 2 | 11719382 | |
| Pubmed | A single binding motif is required for SPAK activation of the Na-K-2Cl cotransporter. | 5.65e-05 | 2 | 262 | 2 | 17595523 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF845 ZNF585A ZNF155 ZNF175 ZNF180 PPP1R13L ZNF551 ZNF331 ZNF610 ZNF345 NPHS1 GPI ZNF573 ZNF577 ZNF570 ZNF818P ZNF329 PDCD2L ZNF865 CHST8 ZNF419 ZNF45 ZNF256 ZNF814 ZNF888 ZNF83 ZNF582 | 1.56e-09 | 1192 | 262 | 27 | chr19q13 |
| Cytoband | 19q13.43 | 1.12e-05 | 87 | 262 | 6 | 19q13.43 | |
| Cytoband | 9q34.2 | 9.74e-05 | 16 | 262 | 3 | 9q34.2 | |
| Cytoband | 3p21.2 | 1.66e-04 | 19 | 262 | 3 | 3p21.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF845 ZNF148 ZNF585A ZNF155 ZNF658 ZNF175 ZNF180 TRPS1 ZBTB8B ZNF267 ZNF621 IKZF1 ZNF217 ZNF362 BCL11A ZNF551 ZNF331 ZNF462 ZNF610 ZNF345 ZNF573 ZNF577 ZNF570 ZNF329 ZNF407 ZNF397 ZNF865 ZNF710 ZNF419 ZNF12 ZNF800 BCL11B GZF1 CTCF ZNF45 ZNF256 ZKSCAN3 ZNF814 ZNF888 ZNF721 ZNF83 ZBTB3 ZNF582 | 7.87e-21 | 718 | 191 | 43 | 28 |
| GeneFamily | Ankyrin repeat domain containing | PPP1R13L KANK1 TONSL OSBPL1A MIB1 UACA GIT1 ANKRD44 RNASEL KANK4 TANC1 MYO16 | 1.05e-05 | 242 | 191 | 12 | 403 |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | IKZF1 TSC2 ITPR1 FER ORC5 SLC12A2 AKAP11 EIF2AK2 PCDH7 MYO16 | 2.32e-05 | 181 | 191 | 10 | 694 |
| GeneFamily | Ubiquitin specific peptidases | 3.08e-04 | 56 | 191 | 5 | 366 | |
| GeneFamily | Ankyrin repeat domain containing|KN motif and ankyrin repeat domain containing | 6.57e-04 | 4 | 191 | 2 | 623 | |
| GeneFamily | SH2 domain containing | 7.09e-04 | 101 | 191 | 6 | 741 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.76e-03 | 23 | 191 | 3 | 1288 | |
| GeneFamily | Phosphodiesterases | 1.99e-03 | 24 | 191 | 3 | 681 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 2.98e-03 | 8 | 191 | 2 | 658 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | SPTAN1 KL OSBPL1A PITPNM2 UACA GIT1 TGFBR2 SLC12A2 KANK4 TANC1 ADAMTSL2 | 3.11e-08 | 200 | 262 | 11 | 7034f57e282982c19c13ee8ab78eabaffa069e30 |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ITGAX TYK2 OSBPL8 STK39 ODAD3 FCHSD1 PIGL ZNF865 ANKRD44 S1PR4 | 8.35e-08 | 173 | 262 | 10 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-07 | 185 | 262 | 10 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | TENM2 ZNF331 FBN2 EXOC6B NRAP MYH7B TANC1 MAPK4 PCDH7 MYBPC3 | 1.91e-07 | 189 | 262 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.55e-07 | 195 | 262 | 10 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 199 | 262 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.07e-07 | 199 | 262 | 10 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | SPTAN1 KL PITPNM2 UACA GIT1 TGFBR2 SLC12A2 KANK4 TANC1 ADAMTSL2 | 3.22e-07 | 200 | 262 | 10 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.22e-07 | 162 | 262 | 9 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.22e-07 | 162 | 262 | 9 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-07 | 170 | 262 | 9 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 176 | 262 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | INPP5D IKZF1 BCL11A MAP3K1 ITPR1 KLHL14 ARHGEF18 ANKRD44 DAPP1 | 1.04e-06 | 176 | 262 | 9 | d2c353783bd78dc24f28e00d917b88d8294fb5df |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.10e-06 | 177 | 262 | 9 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.32e-06 | 181 | 262 | 9 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.51e-06 | 184 | 262 | 9 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | background-B_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | INPP5D IKZF1 BCL11A MAP3K1 ITPR1 KLHL14 ANKRD44 ADAMTS6 DAPP1 | 1.81e-06 | 188 | 262 | 9 | 9acb7a95e3095f15918a5d094107d1d565a42842 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.89e-06 | 189 | 262 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | PDE1C ZNF331 DCLK2 PITPNM2 UACA SLC12A2 TMEM44 TANC1 ADAMTSL2 | 1.97e-06 | 190 | 262 | 9 | 0a351609a72fd638c84b2435782e312ee6a33aac |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.97e-06 | 190 | 262 | 9 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.65e-06 | 197 | 262 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 2.76e-06 | 198 | 262 | 9 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 200 | 262 | 9 | 66f7e8ee63c828f17468e79a4b816346b33e8980 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 7.08e-06 | 168 | 262 | 8 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.39e-06 | 169 | 262 | 8 | b2d53159e344fad6fcdc485d5b8f6cf1bf094b1f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.72e-06 | 170 | 262 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 173 | 262 | 8 | 1cfbab6603f8baf8e238837bb72740c43a7dc0ec | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 173 | 262 | 8 | 49030c2dd04b592655df1a667e2f90efb499e0a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.77e-06 | 173 | 262 | 8 | 73f858f2c45d19b9ec8d99ac02c91551790f670c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.77e-06 | 173 | 262 | 8 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.94e-06 | 176 | 262 | 8 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 177 | 262 | 8 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 262 | 8 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 262 | 8 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 180 | 262 | 8 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-05 | 181 | 262 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-05 | 181 | 262 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-05 | 132 | 262 | 7 | a1fda8c5287168c4f159203ed27cadfb4ce1b131 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 184 | 262 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 184 | 262 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 184 | 262 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.43e-05 | 185 | 262 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.43e-05 | 185 | 262 | 8 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.49e-05 | 186 | 262 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.49e-05 | 186 | 262 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.49e-05 | 186 | 262 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.54e-05 | 187 | 262 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.60e-05 | 188 | 262 | 8 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-05 | 188 | 262 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-05 | 189 | 262 | 8 | 7ac78441a15a82218deaafd47accff2ea5c8de20 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-05 | 189 | 262 | 8 | 389ccb68acb82893709f256315111470cf4beed3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.67e-05 | 189 | 262 | 8 | 58465b9407fbce91cca8f199950d6e0054c38fbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 190 | 262 | 8 | d4f954e0748898df69e1710df558564db703dd61 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.80e-05 | 191 | 262 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-05 | 139 | 262 | 7 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 192 | 262 | 8 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.94e-05 | 193 | 262 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.94e-05 | 193 | 262 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.94e-05 | 193 | 262 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.94e-05 | 193 | 262 | 8 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 195 | 262 | 8 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 195 | 262 | 8 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 195 | 262 | 8 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 196 | 262 | 8 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 196 | 262 | 8 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-05 | 196 | 262 | 8 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 196 | 262 | 8 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.25e-05 | 197 | 262 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 197 | 262 | 8 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-05 | 197 | 262 | 8 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.25e-05 | 197 | 262 | 8 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-05 | 198 | 262 | 8 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-05 | 198 | 262 | 8 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-05 | 200 | 262 | 8 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.50e-05 | 200 | 262 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.50e-05 | 200 | 262 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.50e-05 | 200 | 262 | 8 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.50e-05 | 200 | 262 | 8 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-05 | 200 | 262 | 8 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.55e-05 | 146 | 262 | 7 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-05 | 150 | 262 | 7 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-05 | 157 | 262 | 7 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-05 | 157 | 262 | 7 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.77e-05 | 161 | 262 | 7 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.16e-05 | 163 | 262 | 7 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.57e-05 | 165 | 262 | 7 | 479962ce1c3d6636ae62b6709635299748653801 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-05 | 165 | 262 | 7 | 7039bb5a7af4684fbd1192230864e5cd6936e83c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-05 | 165 | 262 | 7 | d2c79653710b139794170f3d72f11392fc548ac7 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-05 | 168 | 262 | 7 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-05 | 168 | 262 | 7 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.24e-05 | 168 | 262 | 7 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.48e-05 | 169 | 262 | 7 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-05 | 170 | 262 | 7 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-05 | 170 | 262 | 7 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 6.72e-05 | 170 | 262 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 170 | 262 | 7 | ece7c20e89c190a7ec68032b6c2efeb458c43f9a | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.72e-05 | 170 | 262 | 7 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-05 | 171 | 262 | 7 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-05 | 171 | 262 | 7 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-05 | 172 | 262 | 7 | e680abead2da75e50774da02384eb2729c839c01 | |
| Disease | Colorectal Carcinoma | ZNF155 ABCA13 MCF2L2 ZBTB8B ZNF217 PAK6 LRRC47 KMT2C BMP4 KL FBN2 WDR49 FRMPD2 STAM CHST8 TGFBR2 TNNI3K BCL11B ZKSCAN3 TENM1 | 3.03e-06 | 702 | 252 | 20 | C0009402 |
| Disease | reticulocyte measurement | ARHGAP42 USP34 ATR INPP5D TRPS1 PPIL6 PEX12 IKZF1 ZNF217 BCL11A ITGAX MAP3K1 KEL METAP2 MED12 PITPNM2 ZNF800 BCL11B SLC12A2 PDE5A EIF2AK2 GAA S1PR4 MYBPC1 | 1.38e-05 | 1053 | 252 | 24 | EFO_0010700 |
| Disease | Polycystic kidneys, severe infantile with tuberous sclerosis | 7.27e-05 | 2 | 252 | 2 | C1838327 | |
| Disease | oxoglutarate dehydrogenase deficiency (implicated_via_orthology) | 7.27e-05 | 2 | 252 | 2 | DOID:0081326 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | ATR PAK6 MAP3K1 ITPR1 KMT2C VPS52 BRPF1 USP7 MED12 LAMB2 TGFBR2 RNASEL SLC12A2 CTCF INTS4 EIF2AK2 | 8.94e-05 | 616 | 252 | 16 | C0033578 |
| Disease | reticulocyte count | ARHGAP42 USP34 ATR INPP5D TRPS1 PPIL6 PEX12 IKZF1 ZNF217 BCL11A ITGAX MAP3K1 PKD1 KEL METAP2 MED12 PITPNM2 ZNF800 THADA EIF2AK2 GAA S1PR4 | 1.02e-04 | 1045 | 252 | 22 | EFO_0007986 |
| Disease | neuroimaging measurement | MYH10 TRPS1 EXT1 PAK6 MAP3K1 TYK2 ZNF462 FBN2 PKD1 METAP2 ADAMTS3 SZT2 PAK5 FRYL STAM ORC5 LINC01551 THADA BCL11B PC PCDH7 MYO16 | 1.40e-04 | 1069 | 252 | 22 | EFO_0004346 |
| Disease | CD209 antigen measurement | 2.09e-04 | 14 | 252 | 3 | EFO_0008077 | |
| Disease | Left ventricular noncompaction | 2.09e-04 | 14 | 252 | 3 | C1960469 | |
| Disease | Microprolactinoma | 2.17e-04 | 3 | 252 | 2 | C0344452 | |
| Disease | Macroprolactinoma | 2.17e-04 | 3 | 252 | 2 | C0344453 | |
| Disease | Langer-Giedion Syndrome | 2.17e-04 | 3 | 252 | 2 | C0023003 | |
| Disease | cortical surface area measurement | USP34 MYH10 MFHAS1 EXT1 TENM2 MAP3K1 FBN2 USP38 PKD1 EXOC6B FES METAP2 PITPNM2 PIGL ADAMTS3 GAL3ST4 FRYL TGOLN2 ORC5 LINC01551 THADA BCL11B PC PCDH7 MYO16 | 2.38e-04 | 1345 | 252 | 25 | EFO_0010736 |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.60e-04 | 15 | 252 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | N-acetylmethionine measurement | 2.60e-04 | 15 | 252 | 3 | EFO_0021427 | |
| Disease | hair colour measurement | ARHGAP42 TRPS1 EXT1 LYST MAP3K1 FREM2 POC1B FES MYH7B EPG5 THADA BCL11B TENM4 ZNF83 PC | 2.90e-04 | 615 | 252 | 15 | EFO_0007822 |
| Disease | Malignant neoplasm of prostate | ATR PAK6 MAP3K1 ITPR1 KMT2C VPS52 BRPF1 USP7 MED12 LAMB2 TGFBR2 RNASEL SLC12A2 INTS4 EIF2AK2 | 2.95e-04 | 616 | 252 | 15 | C0376358 |
| Disease | hepatocyte growth factor-like protein measurement | 3.05e-04 | 38 | 252 | 4 | EFO_0008154 | |
| Disease | risk-taking behaviour | MFHAS1 BCL11A TENM2 TAC1 ASCC3 METAP2 PIGL NOA1 ORC5 TNNI3K ZNF800 BCL11B TENM4 ZKSCAN3 MAPK1 PC PCDH7 | 3.37e-04 | 764 | 252 | 17 | EFO_0008579 |
| Disease | sphingomyelin 14:0 measurement | 3.83e-04 | 17 | 252 | 3 | EFO_0010390 | |
| Disease | erythrocyte measurement | 3.92e-04 | 257 | 252 | 9 | EFO_0005047 | |
| Disease | smoking status measurement, systolic blood pressure | 4.03e-04 | 156 | 252 | 7 | EFO_0006335, EFO_0006527 | |
| Disease | prolactinoma (biomarker_via_orthology) | 4.31e-04 | 4 | 252 | 2 | DOID:5394 (biomarker_via_orthology) | |
| Disease | tyrosine-protein kinase TEC measurement | 4.31e-04 | 4 | 252 | 2 | EFO_0020830 | |
| Disease | tuberous sclerosis (is_marker_for) | 4.31e-04 | 4 | 252 | 2 | DOID:13515 (is_marker_for) | |
| Disease | Child Behaviour Checklist assessment | 4.57e-04 | 18 | 252 | 3 | EFO_0005661 | |
| Disease | response to ziprasidone | 6.30e-04 | 20 | 252 | 3 | GO_0097337 | |
| Disease | atopy | 7.14e-04 | 5 | 252 | 2 | EFO_0002686 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 7.14e-04 | 5 | 252 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | blood pressure | 8.41e-04 | 22 | 252 | 3 | EFO_0004325 | |
| Disease | Tourette syndrome | 8.79e-04 | 50 | 252 | 4 | EFO_0004895 | |
| Disease | N-acetylserine measurement | 1.07e-03 | 6 | 252 | 2 | EFO_0800038 | |
| Disease | Prolactinoma | 1.07e-03 | 6 | 252 | 2 | C0033375 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.10e-03 | 53 | 252 | 4 | C4707243 | |
| Disease | IGFBP-3 measurement | 1.18e-03 | 54 | 252 | 4 | EFO_0004626 | |
| Disease | disease recurrence, response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement | 1.48e-03 | 7 | 252 | 2 | EFO_0004952, EFO_0007044, EFO_0007892 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.58e-03 | 145 | 252 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | Unilateral agenesis of kidney | 1.97e-03 | 8 | 252 | 2 | C0266294 | |
| Disease | Sudden Cardiac Death | 1.97e-03 | 8 | 252 | 2 | C0085298 | |
| Disease | cardiovascular disease | ARHGAP42 USP34 ABCF3 FBN2 USP38 AGXT FES ARHGEF18 THADA BCL11B MYBPC3 | 2.04e-03 | 457 | 252 | 11 | EFO_0000319 |
| Disease | brain connectivity measurement | MFHAS1 EXOC6B FES DCLK2 METAP2 NT5C1B BCL11B TENM4 PCDH7 MYO16 | 2.46e-03 | 400 | 252 | 10 | EFO_0005210 |
| Disease | Calcium channel blocker use measurement | 2.46e-03 | 213 | 252 | 7 | EFO_0009930 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.49e-03 | 335 | 252 | 9 | EFO_0009931 | |
| Disease | glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 2.51e-03 | 9 | 252 | 2 | EFO_0800476 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.91e-03 | 69 | 252 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | ABCF3 TRPS1 RABGAP1 MAP3K1 ZNF462 FBN2 MIB1 FES METAP2 ADAMTS3 THADA BCL11B | 2.91e-03 | 550 | 252 | 12 | EFO_0004346, EFO_0004464 |
| Disease | breast carcinoma | TRPS1 EXT1 MAP3K1 ITPR1 FBN2 KLHL14 NRAP ZNF577 TTC28 LAMB2 TGFBR2 ARHGAP5 SLC12A2 ZNF45 ZKSCAN3 NIPAL1 PADI6 MYBPC1 | 3.07e-03 | 1019 | 252 | 18 | EFO_0000305 |
| Disease | Marfan syndrome (implicated_via_orthology) | 3.12e-03 | 10 | 252 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 3.39e-03 | 72 | 252 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | cortical thickness | ABCF3 NUP210L TRPS1 EXT1 RABGAP1 TENM2 MAP3K1 ZNF462 BMP4 FBN2 ANGPT4 PKD1 PITPNM2 ADAMTS3 ORC5 THADA BCL11B PCDH7 MYO16 | 3.45e-03 | 1113 | 252 | 19 | EFO_0004840 |
| Disease | diastolic blood pressure, alcohol drinking | 3.49e-03 | 118 | 252 | 5 | EFO_0004329, EFO_0006336 | |
| Disease | response to statin, myopathy | 3.80e-03 | 11 | 252 | 2 | EFO_0004145, GO_0036273 | |
| Disease | Dermatologic disorders | 3.93e-03 | 75 | 252 | 4 | C0037274 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 4.48e-03 | 39 | 252 | 3 | EFO_0008298 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 4.53e-03 | 12 | 252 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | Crohn's disease | SLAMF8 USP34 MAPKAPK2 IKZF1 TYK2 THADA BCL11B CELSR3 KANK4 AKAP11 | 4.88e-03 | 441 | 252 | 10 | EFO_0000384 |
| Disease | systolic blood pressure, alcohol drinking | 4.93e-03 | 128 | 252 | 5 | EFO_0004329, EFO_0006335 | |
| Disease | epilepsy | 5.16e-03 | 41 | 252 | 3 | EFO_0000474 | |
| Disease | Malignant neoplasm of breast | PDE2A SPTAN1 RPS6KB2 MCF2L2 BCL11A MAP3K1 BMP4 FGF3 TIMELESS MED12 PLEKHA8 GPI NOA1 B3GALNT2 SLC25A51 EPG5 TENM1 ZBTB3 | 5.27e-03 | 1074 | 252 | 18 | C0006142 |
| Disease | tyrosine-protein kinase receptor Tie-1, soluble measurement | 5.33e-03 | 13 | 252 | 2 | EFO_0008312 | |
| Disease | Eczema | 5.40e-03 | 310 | 252 | 8 | HP_0000964 | |
| Disease | obsolete_red blood cell distribution width | ARHGAP42 ATR PEX12 ZNF217 BCL11A ITGAX MAP3K1 LRRC47 FBN2 STK39 TTC28 DUOX2 ZNF407 FREM3 EPG5 ZNF800 SLC12A2 DAPP1 STKLD1 EIF2AK2 MYO16 | 6.04e-03 | 1347 | 252 | 21 | EFO_0005192 |
| Disease | polycystic kidney disease (implicated_via_orthology) | 6.18e-03 | 14 | 252 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | cognitive impairment measurement | 6.30e-03 | 44 | 252 | 3 | EFO_0007998 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.71e-03 | 45 | 252 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | caffeine measurement | 7.09e-03 | 15 | 252 | 2 | EFO_0021177 | |
| Disease | major depressive episode | 7.57e-03 | 47 | 252 | 3 | EFO_0007634 | |
| Disease | C-reactive protein measurement | SLAMF8 USP34 MFHAS1 NUP210L TRPS1 MAP3K1 ITPR1 POC1B PKD1 EXOC6B UVRAG DOCK3 RPGRIP1 PIGL ZNF573 OR4C11 ATP8B2 ANKRD44 MYBPC3 | 7.95e-03 | 1206 | 252 | 19 | EFO_0004458 |
| Disease | hippocampal CA1 volume | 8.02e-03 | 48 | 252 | 3 | EFO_0009394 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 8.06e-03 | 16 | 252 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Inherited oocyte maturation defect | 8.06e-03 | 16 | 252 | 2 | cv:CN238505 | |
| Disease | uterine prolapse | 8.06e-03 | 16 | 252 | 2 | EFO_1001864 | |
| Disease | Ischemic stroke, coronary artery disease | 8.07e-03 | 92 | 252 | 4 | EFO_0001645, HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKSYRGNQNHLHLTL | 61 | Q9BXU7 | |
| HAQVGVRLINSVNHY | 386 | Q96P26 | |
| QQHKNALGYHCDRSL | 1191 | Q9HCE0 | |
| VYDRGHLLQRHTQSN | 661 | Q8NEM8 | |
| GHNEAVSHYKLLLQQ | 556 | Q6ZSZ5 | |
| RHLGKNNVLYSAHDV | 91 | Q86U37 | |
| DLGVHLRKQHSYIEQ | 451 | P49711 | |
| TSNYLLGLLAHQVHD | 461 | O15254 | |
| LSYSLRFGGQKHVVH | 61 | Q9UKJ8 | |
| TRGYIQARLHLQHEN | 321 | O43306 | |
| HHAQDYGGLLLLATA | 691 | P35606 | |
| RIHGHLYVNKVAGNF | 171 | Q96RQ1 | |
| RNSLYQHIKVHTGER | 531 | Q9H116 | |
| ATDIIHLHSQRLDGY | 391 | Q9NUQ8 | |
| GSLRYLVQQHLDLLH | 311 | A8MVX0 | |
| ALDENLHQLHLTGYG | 4131 | Q86UQ4 | |
| GIRYTLDTFLHQKHQ | 151 | Q9UKA4 | |
| YARQAGHHELAERLV | 206 | Q9Y2X7 | |
| TAHLYSLLQTQHALG | 151 | P53365 | |
| LGNHETNYTLHLVAI | 351 | Q9Y5C1 | |
| YRSHVLHSLLEGFVQ | 546 | Q9Y4B4 | |
| RHAVYQAEHLLQTAG | 151 | P78325 | |
| NYGLAIEVTHLHQTR | 231 | P12644 | |
| ANDLALRLARHYTGH | 116 | Q8IUZ5 | |
| AYGKHFHLNLTLNTD | 91 | Q9UKP5 | |
| EYALVINGHSLAHAL | 771 | P98198 | |
| DTGQLYAALHHRILA | 496 | Q9H6Z4 | |
| QRAIKAELHLLNVHY | 601 | Q6ZP01 | |
| QLHERGLKLHQTIYN | 221 | Q96HW7 | |
| AIQNVVHRLFHASYG | 231 | P20702 | |
| LYKLHDRLAQLAGDH | 531 | Q9Y2U8 | |
| YQGTAHRHTAEVLLA | 1261 | Q9H1A4 | |
| LSYLHNQGVIHRDIK | 556 | Q9P286 | |
| GCHNNDHLVEKYRIL | 581 | Q9Y3P9 | |
| AHHYSVALRRLGQLL | 111 | Q14296 | |
| GLKYIHSANVLHRDL | 136 | P28482 | |
| LRIHHAKLAQAGAYQ | 801 | O60500 | |
| QHAYTLALLGNHLKE | 241 | Q6TGC4 | |
| LLQHYQLHSAAVNGL | 221 | Q8NBT0 | |
| QGLKRLHTVHLYNNA | 356 | Q7Z5L7 | |
| LQALAYLHAQGVIHR | 511 | Q9NQU5 | |
| YLHAQGVIHRDIKSD | 516 | Q9NQU5 | |
| HNILGQAYIELRHRA | 2551 | Q8NEZ4 | |
| HVRAQYVALLQRSHG | 56 | O75610 | |
| RNLNGHSIGQYRIHA | 326 | P50579 | |
| GEAIQYLHSINIAHR | 171 | P49137 | |
| RATQLHQYVEGFLLH | 781 | Q9Y4C4 | |
| VHARKAQHLATDVGY | 881 | Q86VF7 | |
| GHNIYILAHQLARHN | 2161 | Q14643 | |
| QKFHYRNLLLGEHDV | 86 | Q9NXD2 | |
| EEKYGLHLNNLCAHR | 606 | Q9Y6X6 | |
| GLKYIHSANVLHRDL | 136 | P31152 | |
| SVSGLHRYLHLLDGN | 431 | Q8N1G4 | |
| ATKYHLQLHPSGRVN | 51 | P11487 | |
| HLEDIKQGRVSYAHN | 891 | Q5SZK8 | |
| LQHAQNTHGLRIYLE | 186 | Q9H165 | |
| NALRYLHGLSIVHRD | 501 | Q8N568 | |
| VLAILHSAGHAVNVY | 1136 | Q9NRD8 | |
| ALVGDQLIQSHHYAA | 381 | Q86YR7 | |
| TANRGKHVAYIIRSH | 96 | Q5VSP4 | |
| HLNEASVLHNLRQRY | 136 | A7E2Y1 | |
| AVQSLIRAYQIRGHH | 116 | Q9ULD0 | |
| IRAYQIRGHHVAQLD | 121 | Q9ULD0 | |
| HYGLHRLVVQVNDSG | 811 | O60245 | |
| VLHTLRQRYGASLLH | 421 | Q92614 | |
| HAHSLLRDYQQREGI | 206 | Q9BRP1 | |
| VLENHHLSAAYRLLQ | 296 | Q14123 | |
| VGYDRNNKQHHRLLL | 786 | O00408 | |
| LSHDLDHRGVNNSYI | 651 | O76074 | |
| LDIYSGLNSHLNRQH | 1511 | O94915 | |
| AGHKDIAVLLYAHVN | 1311 | Q14678 | |
| RKGNAHLGYSLVTHI | 221 | Q86TH1 | |
| QHLDLLKHSNFLGAY | 1316 | P55268 | |
| RGEEQQRLLLYHTHL | 1716 | Q93074 | |
| LRENLLHGALEHYVN | 181 | Q9UHN1 | |
| SLTLNTNHGHILVDY | 41 | P06744 | |
| YNGHHQALEVLLQSL | 576 | Q8N8A2 | |
| HILHTTQGLVNRAYI | 356 | Q9Y2D4 | |
| LIGISKAIHYLHNVQ | 271 | Q9Y616 | |
| RVNKLLQHYQVHSGG | 216 | Q8TC44 | |
| TALNNAYGKTLRQHH | 431 | Q96JA3 | |
| HARNGLSLKEEHRAY | 421 | Q13422 | |
| YIVILHSLRNHSAKG | 216 | Q6IEV9 | |
| LISELHLRVHAAYGS | 1196 | Q9BZ72 | |
| LHYKNSIFHRIVQNG | 191 | Q8IXY8 | |
| DAVHNIYRQGCKHLT | 271 | Q9BXW6 | |
| SVLSLLHRYGDQHGL | 81 | Q96RP7 | |
| RQALYQFLHNGSHLR | 281 | Q96PC2 | |
| SSAHVYLRLHKGENI | 46 | Q86WR0 | |
| GNYLLLTHKHVAQLS | 611 | Q8TE96 | |
| NHARYSILENGFLHI | 3756 | Q96RW7 | |
| DGYTALHLAALNNHV | 631 | Q86YT6 | |
| LVNYHRAQSLSHGLR | 151 | Q13882 | |
| VLRTHGVDHLSYNEL | 126 | Q9H0J9 | |
| HVTFYGLLRANNLHS | 291 | Q9BZF1 | |
| HGVSLQQRHLFRTYK | 261 | Q9NR21 | |
| AARDYKIQNHGHRVL | 336 | Q86WN1 | |
| QSLIRAYQIRGHHVA | 131 | Q02218 | |
| ARKAGHHQTAYNALL | 1931 | Q13535 | |
| HILAIKNQATGHYIL | 751 | O15072 | |
| HQLKRLEEHRYQSAG | 46 | Q9Y6K0 | |
| LAAHAGAVHNGKIYI | 461 | Q9P2G3 | |
| LLQHAQNTHGFRIYL | 236 | Q9C0K0 | |
| LAHVLAAHTAQGDYQ | 186 | A8MY62 | |
| LRSLISQYQHKQVHG | 1521 | Q8IZD9 | |
| NALYHVHNGEDVVLL | 281 | Q16394 | |
| FQLLRGLAYIHHQHV | 206 | Q96Q40 | |
| ALAKLDHVNIVHYNG | 311 | P19525 | |
| LHNQYVLALKGAQLH | 181 | P16591 | |
| GLLQHSLTRHQFYLQ | 436 | Q68DX3 | |
| GLAHRRAALLHYENL | 311 | O43559 | |
| IYTIQEGDALLHNLH | 276 | Q8NCR0 | |
| YHGNLTRHAAEALLL | 36 | Q9UN19 | |
| HFHLGSENQLYRLSV | 396 | Q9Y264 | |
| SLQAHLKVDVYGRSH | 211 | P51993 | |
| EYRSLQLQEHRLLHG | 191 | O60759 | |
| TNFEYLTHLNKHAGR | 3141 | Q99698 | |
| LHNLYGLTEAIASHR | 571 | P10253 | |
| LLHIRAVGTNSTLHY | 56 | Q8WWB7 | |
| GIQQHYKHAVRQSFR | 31 | A8MSI8 | |
| SRVSHQVAYGLHELL | 1236 | Q92538 | |
| LVNLADHNGNTALHY | 816 | Q5T7N3 | |
| TYSAGHNLLKAHALA | 696 | Q9UEF7 | |
| NHYVVGAERKQLAHS | 176 | Q04743 | |
| RIHQRNGLSYLHTAK | 2846 | P35556 | |
| GLLAVNHSILAFHYL | 2741 | Q9NYQ7 | |
| AHKLAYLVGQSIHQE | 856 | Q7Z3Z3 | |
| LHNCIIYNGGNHKLT | 221 | Q9ULU4 | |
| LAAGGHSRLIVLHYN | 16 | O95977 | |
| QHYHAKFLGSLRARL | 241 | Q12770 | |
| KQYQQIISRLFHRHG | 541 | Q8WUF5 | |
| NLAHVTNAGIYFHLI | 466 | Q16820 | |
| VIQYLAHVASSHKGR | 191 | P35580 | |
| ILSSYFLNEHLNIHG | 156 | Q6NVV3 | |
| LDRADALYQKHAGHT | 571 | Q8NC60 | |
| VGAHIAILSYNSHAR | 1796 | A6NMZ7 | |
| HQTEGDHLTLLAVYN | 1036 | Q14562 | |
| HYILELQDHRVALNG | 291 | Q5VU65 | |
| GHAYRLQSAIKQELH | 3696 | P98161 | |
| YLALAHNRVSSLNHA | 26 | Q96MR7 | |
| YLLHTHLAGRALQAV | 386 | A6NHM9 | |
| AHHNRYVLGVRAAQL | 181 | P07332 | |
| GLSYLHENQIIHRDV | 1356 | Q13233 | |
| LSILGKRNYSHHNGL | 571 | Q9BTC8 | |
| LFDRAVVLSHYIHNL | 46 | P01236 | |
| YEGEKNSLTLQHLHV | 1081 | P0C091 | |
| YADRAKHIVNHAVVN | 346 | Q9NQT8 | |
| ALNNAYGKTLRQHHG | 316 | O95397 | |
| LSQKLGLFHHYGQLD | 2696 | Q5T011 | |
| RNGHQLLDTYFTLHL | 56 | Q9P2Y5 | |
| ASHAARNHYEVLVLG | 36 | Q9Y6N5 | |
| HREAAAYLHGRLQAL | 291 | P21549 | |
| SVYHVDRQRKHQLLG | 231 | Q9BQS2 | |
| EIGDYFKQHLLQSRH | 1091 | Q6YHU6 | |
| LHYLQEASARLDIHQ | 691 | Q96KN7 | |
| IIEYHKHNAAGLVTR | 326 | P42680 | |
| ALGHLHSQGIIYRDL | 181 | Q9UBS0 | |
| NHIALYAAVRALHSE | 156 | Q9Y2B2 | |
| QNYRVEAVHALVHKL | 486 | A6NI28 | |
| INLFRGAHLNYHRSL | 266 | Q9H1U9 | |
| YLKNRTGQALEHLDH | 141 | A5D8V7 | |
| DYSIGNLQKILSHDH | 181 | O43913 | |
| LRQHAYEHSLGKLRA | 246 | O60664 | |
| NYDHSLVKVLLSHGA | 311 | Q05823 | |
| HQNSRTRLLYGKNHV | 251 | O43147 | |
| LHLQHSKGRDYRDNT | 1151 | Q92835 | |
| AFHAKGNLQEYLTRH | 326 | P37173 | |
| VHSALRGHGDILQYL | 1006 | Q9C0D5 | |
| GTHLHTLNLITRDYV | 1551 | Q9UKZ4 | |
| GRRASYKTNLGHHLQ | 2306 | Q9NT68 | |
| HGRLRLYHDSTNIDK | 581 | Q13017 | |
| ELIHLNHRYQGKFLN | 151 | Q8WYR4 | |
| INLFRGAHLNYHRSL | 266 | Q3SY17 | |
| VQQLRYILGKAQHHS | 176 | O00623 | |
| AYHRALQHRSKVQGE | 1191 | P55201 | |
| KRVGYIRNHHVASLS | 2131 | Q8N3C0 | |
| DIQHNTVHYGSALKR | 221 | Q9H2A9 | |
| LQRAIAYQHSGHLES | 146 | Q5T681 | |
| YSSVLRKHQIIHLGA | 226 | Q96IR2 | |
| RGQSALIYHQAIHGI | 561 | Q96IR2 | |
| RKLYLTNHQRIHTGE | 411 | Q8N9Z0 | |
| GYHQRVHGADALSLQ | 91 | O14603 | |
| TAAILVAVLYIAHHN | 391 | O43493 | |
| GALTQLIQLYHRFHR | 676 | Q8N1B4 | |
| IFHKGLHNLRNYSSD | 296 | Q9UNS1 | |
| YHLGLHNRTRQDAEL | 246 | Q9UHF7 | |
| RLGLTYHVHDLIGAQ | 336 | P49842 | |
| NLLEHQRLHLGERAY | 946 | P0CJ78 | |
| HSLHGLFNVRYLNLK | 316 | O15455 | |
| TASYFLLHQRIHKGG | 341 | Q86YE8 | |
| LGDHKAARDNYLHAL | 326 | A2A3L6 | |
| RAVYAVAHGLHQLLG | 391 | Q7RTX1 | |
| LTHRITLANIHLAYA | 296 | P60852 | |
| LQHGCRVLQTKAHQY | 1746 | Q99973 | |
| LQKYHTINGHNAEVR | 171 | P22626 | |
| NVLGQVLDALEYLHH | 136 | Q8NE28 | |
| HLYARQLTLEQLHAV | 111 | Q9BRJ7 | |
| LLAGHGRYAEALEQH | 36 | Q96HA7 | |
| YGHDLASVQALQRKH | 1261 | Q13813 | |
| CLTQHRKIHTGENLY | 506 | Q14586 | |
| SYKHVRVQHQGDLIR | 221 | Q9Y2P7 | |
| QSANLYVHRRIHTGE | 556 | Q8TF20 | |
| QKAYLTAHQRLHTGD | 281 | Q9BSK1 | |
| HYRHTAAQLGEKLLR | 226 | P55011 | |
| QHVLHRNLIYLATIA | 51 | Q9UHA2 | |
| YHVDRQRKHQLLGQV | 286 | X6R8R1 | |
| GIHAFDYHSRLNLIA | 21 | Q8IV35 | |
| YKSNLIEHQRVHTGE | 346 | Q7Z340 | |
| SRGYQLSQHQKIHTG | 141 | Q9NQX6 | |
| YRLHAVLVHEGQANA | 591 | Q9UHP3 | |
| SKYNLVTHILGHNGI | 306 | Q8N1W2 | |
| GRRVAAILNHAHYLE | 2591 | Q6N022 | |
| TNHQHEGRKVRAIYD | 206 | Q92783 | |
| AGLLYASAIVAHDQH | 271 | Q2T9K0 | |
| LYHSRFLGRAQLHSN | 71 | Q9P0V8 | |
| HIQQAKYQGRLHVSH | 76 | Q9Y279 | |
| LANLLIHYGLHLDAT | 661 | Q96AE7 | |
| VQNLLGHYLIHGFRV | 56 | Q9NNW5 | |
| NKTFVLGLLHQGYHS | 81 | Q8NB14 | |
| HLNIHQKIHTGERQY | 536 | Q6P3V2 | |
| LIQHQTVHTGRKLYE | 326 | Q96NG8 | |
| GRNALHLAAKYGHAL | 101 | Q9BZF9 | |
| IAIYRTHLLSAAQGH | 1381 | Q9BZF9 | |
| ALYQKLDFTAHQRIH | 361 | Q5TYW1 | |
| QSYKLIAHQRIHTGE | 476 | Q9UJW8 | |
| DSYLAQHQRVHTGEK | 646 | P0CJ79 | |
| RSAAYLQHQRLHTGE | 246 | Q6ZSS3 | |
| SKGNYREALTNHRHQ | 286 | Q96AY4 | |
| SYQALQRVLVSLGHH | 1171 | Q96AY4 | |
| IAYLAQHQRVHTGEK | 426 | Q96NI8 | |
| SYLIIHQRIHSGEKA | 326 | Q8NF99 | |
| SYLVQHQRSHVGKNI | 521 | Q9BRR0 | |
| NASYLAQHLRIHLGV | 266 | Q5T0B9 | |
| LVNHQRIHTGEKSYR | 76 | Q6ZRF7 | |
| GYVTKFNLDLHQRVH | 436 | Q12901 | |
| RHIENIHLSGKTAVY | 456 | Q96JM2 | |
| GKAFRTYHQLVLHSR | 381 | O75362 | |
| LTKHIELHTDGNNIY | 501 | Q2TB10 | |
| ALNRHQRTHTGEKAY | 591 | P17014 | |
| LQTLLDHYSHKANGQ | 541 | Q9UQR1 | |
| LTQHQRIHTGEKLYE | 441 | Q14585 | |
| ENLLNAHYLGKTHLR | 256 | Q9C0G0 | |
| AHYLGKTHLRRQNLA | 261 | Q9C0G0 | |
| QTVREGRQKHALYSH | 966 | Q70CQ2 | |
| GRQKHALYSHSAEVQ | 971 | Q70CQ2 | |
| RYSHTAHVLNGKLLL | 586 | O60294 | |
| VLYAFRILALNHHTA | 671 | P0DP72 | |
| VLEGLDYLHRNGQIH | 176 | Q9UEW8 | |
| DYLHRNGQIHRDLKA | 181 | Q9UEW8 | |
| AFGQKYLLVQHQRLH | 211 | Q96HQ0 | |
| HRDLNSHNILLYEDG | 586 | Q59H18 | |
| VALLKALYGHGQISH | 81 | P20366 | |
| ANYILHAVLVHSGDN | 446 | Q93009 | |
| SKNYNLIVHQRIHTG | 241 | Q86UD4 | |
| RHGKHYFIEVNSRLQ | 316 | P11498 | |
| SQRSYLQVHLKVHTG | 286 | Q02386 | |
| RNKYQLIAHQRVHTG | 726 | B7Z6K7 | |
| LIIHQKIHTGERQYA | 406 | Q9Y473 | |
| RNSYLAQHLIIHAGE | 356 | P51522 | |
| DNSYLVRHQRFHAGK | 496 | P51522 | |
| HLVYVRLALSSDAHG | 136 | Q2WGJ8 | |
| HRHGAINSAAILLYA | 336 | O15321 | |
| RNLLGTHLGHSAIYN | 261 | P49815 | |
| AQHYIHRDLAARNVL | 1016 | P29597 | |
| QSGDLYRHIRKAHNE | 511 | Q9H5J0 | |
| ALLIHYIQDSGRHST | 51 | Q8NAP8 | |
| LQAYSKRLLRHHGET | 646 | P23276 | |
| YALHGIRYKNDHINL | 481 | Q8IYS2 | |
| VYHINLKNEAGEAHA | 596 | Q00872 | |
| SKVGQHLQLHDSYDR | 201 | Q14896 | |
| AQELALLHSKYGLHV | 76 | Q96NY8 |